# WAC 182-530-2000: WAC 182-530-2000. Covered — Outpatient drugs, devices, and drug-related supplies

> Washington · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_2000

## Section

- **Citation:** WAC 182-530-2000
- **Heading:** WAC 182-530-2000. Covered — Outpatient drugs, devices, and drug-related supplies
- **Jurisdiction:** Washington
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** Washington Administrative Code / Title 182 / Chapter 182-530 / Section 182-530-2000

## Text

(1) The medicaid agency covers:
(a) Outpatient drugs, including over-the-counter (OTC) drugs, as defined in WAC 182-530-1050 , subject to the limitations and requirements in this chapter, when:
(i) The drug is approved by the Food and Drug Administration (FDA);
(ii) The drug is for a medically accepted indication as defined in WAC 182-530-1050 ;
(iii) The drug is not excluded from coverage under WAC 182-530-2100 ;
(iv) The manufacturer has a signed drug rebate agreement with the federal Department of Health and Human Services (DHHS). Exceptions to the drug rebate requirement are described in WAC 182-530-7500 ; and
(v) The drug is prescribed by a provider with prescriptive authority. Exceptions to the prescription requirement exist for family planning and emergency contraception in (b) of this subsection.
(b) Family planning drugs, devices, and drug-related supplies per chapter 182-532 WAC and as follows:
(i) OTC family planning drugs, devices, and drug-related supplies without a prescription when the agency determines it necessary for client access and safety;
(ii) Family planning drugs that do not meet the federal drug rebate requirement in WAC 182-530-7500 on a case-by-case basis; and
(iii) Contraceptive patches, contraceptive rings, and oral contraceptives, excluding emergency contraception, when dispensed in a one-year supply only, unless:
(A) A smaller supply is directed by the prescriber;
(B) A smaller supply is requested by the client;
(C) The pharmacy does not have adequate stock.
(c) Vitamins, minerals, and enzymes when prescribed for:
(i) Prenatal vitamins, when prescribed and dispensed to pregnant women;
(ii) A medical condition caused by a clinically documented deficiency;
(iii) A United States Preventive Services Task Force recommendation with an A or B rating;
(iv) Fluoride for clients under age twenty-one; or
(v) A clinically documented medical condition that causes vitamin, mineral, or enzyme deficiencies, and the deficiency cannot be treated through other dietary interventions.
egnant women;
(ii) A medical condition caused by a clinically documented deficiency;
(iii) A United States Preventive Services Task Force recommendation with an A or B rating;
(iv) Fluoride for clients under age twenty-one; or
(v) A clinically documented medical condition that causes vitamin, mineral, or enzyme deficiencies, and the deficiency cannot be treated through other dietary interventions.
(d) OTC drugs, vitamins, and minerals when determined by the agency to be the least costly therapeutic alternative for a medically accepted indication. All covered OTC products determined to be the least costly therapeutic alternatives for medically accepted indications will be included on the agency's published apple health preferred drug list. This subsection does not apply to products prescribed for the treatment of cough or cold symptoms. See this subsection (1) (h) of this section and WAC 182-530-2100 (1)(b)(v) for coverage of products prescribed for the treatment of cough and cold symptoms.
(e) Drug-related devices and drug-related supplies as an outpatient pharmacy benefit when:
(i) Prescribed by a provider with prescribing authority;
(ii) Essential for the administration of a covered drug;
(iii) Not excluded from coverage under WAC 182-530-2100 ; and
(iv) Determined by the agency that a product covered under chapter 182-543 WAC related to medical equipment and supplies should be available at retail pharmacies.
(f) Preservatives, flavoring, or coloring agents, only when used as a suspending agent in a compound.
(g) OTC and prescription drugs to promote tobacco/nicotine cessation.
(h) For the treatment of cough and cold, only those products included with a preferred status on the apple health preferred drug list (PDL), as described in WAC 182-530-4100 , on the date a client's prescription is dispensed.
(2) The agency does not reimburse for any drug, device, or drug-related supply not meeting the coverage requirements under this section.

## Nearby sections

- [WAC 182-530-1000 WAC 182-530-1000. Outpatient drug program—General](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_1000.md)
- [WAC 182-530-1050 WAC 182-530-1050. Definitions](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_1050.md)
- [WAC 182-530-1075 WAC 182-530-1075. Requirements—Use of tamper-resistant prescription pads](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_1075.md)
- [WAC 182-530-1080 WAC 182-530-1080. Requirements for prescribing and dispensing controlled substances — Prescription monitoring program (PMP)](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_1080.md)
- [WAC 182-530-2000 WAC 182-530-2000. Covered — Outpatient drugs, devices, and drug-related supplies](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_2000.md)
- [WAC 182-530-2100 WAC 182-530-2100. Noncovered — Outpatient drugs and pharmaceutical supplies](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_2100.md)
- [WAC 182-530-3000 WAC 182-530-3000. When the medicaid agency requires authorization](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_3000.md)
- [WAC 182-530-3100 WAC 182-530-3100. How the medicaid agency determines when a drug requires authorization](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_3100.md)
- [WAC 182-530-3200 WAC 182-530-3200. The medicaid agency's authorization process](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_3200.md)
- [WAC 182-530-4000 WAC 182-530-4000. Drug use review (DUR) board](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_4000.md)
- [WAC 182-530-4050 WAC 182-530-4050. Drug use and claims review](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_4050.md)
- [WAC 182-530-4100 WAC 182-530-4100. Medicaid preferred drug list (medicaid PDL)](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_4100.md)
- [WAC 182-530-4125 WAC 182-530-4125. Generics first for a client's first course of treatment](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_4125.md)
- [WAC 182-530-4150 WAC 182-530-4150. Therapeutic interchange program (TIP)](https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_4150.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/STATE_WA_ADC_182_530_2000. Check the current official text before relying on it. Not legal advice.
